Health
EHR data support reported effectiveness of Ad26.COV2.S vaccine – Medical Xpress
The effectiveness of the Johnson & Johnson Ad26.COV2.S vaccine is 73.6 percent for preventing severe acute respiratory syndrome…
The effectiveness of the Johnson & Johnson Ad26.COV2.S vaccine is 73.6 percent for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online Nov. 2 in JAMA Network Open.
Juan Corchado-Garcia,…
Continue Reading
-
General18 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News22 hours agoWest End icon closes doors
-
General18 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire